Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000343667

Medchemexpress LLC Nemonoxacin malate | 951163-60-3 | 99.3% | 505.52 | 1 MG
SDP

Catalog No. 5000343667
Encompass_Preferred

Nemonoxacin malate (TG-873870) is a nonfluorinated quinolone antibiotic that exhibits broad-spectrum activity against Gram-positive, Gram-negative, and atypical pathogens. It can inhibit drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. This product is also utilized in the research of community-acquired pneumonia.

  • Nonfluorinated quinolone antibiotic
  • Broad-spectrum activity against Gram-positive, Gram-negative and atypical pathogens
  • Inhibits drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus
  • Used for the research of community-acquired pneumonia
  • Antibacterial activity against Chlamydia pneumoniae with MIC90s of 0.06 μg/mL
  • Highly active against community-acquired MRSA (CA-MRSA) (MIC90: 0.5 and 0.06 μg/ml)

Catalog No. 50-003-43667 Supplier Medchemexpress LLC Supplier No. HY1110231MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Nemonoxacin malate (TG-873870) is a nonfluorinated quinolone antibiotic that exhibits broad-spectrum activity against Gram-positive, Gram-negative, and atypical pathogens. It can inhibit drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. This product is also utilized in the research of community-acquired pneumonia.

  • Nonfluorinated quinolone antibiotic
  • Broad-spectrum activity against Gram-positive, Gram-negative and atypical pathogens
  • Inhibits drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus
  • Used for the research of community-acquired pneumonia
  • Antibacterial activity against Chlamydia pneumoniae with MIC90s of 0.06 μg/mL
  • Highly active against community-acquired MRSA (CA-MRSA) (MIC90: 0.5 and 0.06 μg/ml)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.